Tokyo moves to address drug industry dilemma
Japan is moving to allow its domestic drug makers to fully contract their manufacturing to other suppliers, responding to growing competition from foreign companies that have long used outsourcing to
Japan is moving to allow its domestic drug makers to fully contract their manufacturing to other suppliers, responding to growing competition from foreign companies that have long used outsourcing to